Title: Validation of Early Dynamic Model (EDM) in Predicting the Outcome of Acute Liver Failure (ALF) in a Cohort of Kashmiri Population: A Prospective Study
Authors: Dr Shabir Ahmad Lone, MD, Dr Imtiyaz Ahmad Khan, MD, Dr Ramees Mohi-ud-din Mir, MD
DOI: https://dx.doi.org/10.18535/jmscr/v8i4.73
Abstract
Introduction
Acute liver failure is used to describe the development of coagulopathy, usually with an international normalized ratio (INR) of greater than 1.5, and any degree of encephalopathy in a patient without preexisting cirrhosis and with an illness of less than 26 weeks duration. Overall incidence of ALF is 1 - 6 cases per million people every year. ALF accounts for up to 7% of all liver-related deaths 4 and is responsible for 6% of liver transplants.(1-6)
References
- Bower W A, Johns M, Margolis H S, Williams I T, Bell B P. Population-based surveillance for acute liver failure. Am J Gastroenterol2007; 102: 2459-63.
- Brandsaeter B, Hockerstedt K, Friman S. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation—12 years experience in the Nordic countries. Liver Transpl2002; 8: 1055–62.
- Escorsell A, Mas A. Acute liver failure in Spain: analysis of 267 cases. Liver Transpl2007; 13; 89–95.
- Hoofnagle J H, Carithers R L, Shapiro C. Fulminant hepatic failure: summary of a workshop. Hepatology. 1995; 21: 240-252.
- Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2007.
- Trey C, Davidson C S. The management of fulminant hepatic failure. 1970: 282-298.
- Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy: a controlled, double-blind clinical trial. Am J Dig Dis. 1978;23 (5):398-406.
- O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993; 342: 273–275.
- O’Grady JG, Williams R. Classification of acute liver failure. Lancet. 1993; 342 (8873): 743.
- Ostapowicz G, Fontana R J, Schiodt F V. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann InternMed 2002; 137:947–954.
- Khuroo M S, Kamili S. Aetiology and prognostic factors in acuteliver failure in India. J Viral Hepat2003; 10: 224–31.
- Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996; 23:1448-1455.
- Tibbs C, Williams R. Viral causes and management of acute liver failure. J Hepatol 1995; 22(Suppl. 1): 68-73.
- Fagan EA, Williams R. Fulminant viral hepatitis. Br Med Bull 1990; 46: 462-80.
- Bjornsson E, Olsson R. Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis 2006; 38: 33–38.
- Wai C-T, Tan B-H, Chan C-L, et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 2007; 27: 465–74.
- Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med 2006; 354: 731–39.
- Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129: 512–21.
- Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005; 42: 481–89.
- Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36: 451–55.
- Bansal J, He J, Yarbough PO. Hepatitis E virus infection in eastern India. Am J Trop Med Hyg 1998; 59: 258-260.
- Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003; 23: 227–37.
- Wei G, Kalaitzakis E, Bergquist A, Bjornsson E. Long-term followup of patients with acute liver failure of indeterminate aetiology. Scand J Gastroenterol 2008; 43: 984–91.
- Woolf GM, Redeker AG. Treatment of fulminant hepatic failure with insulin and glucagon: a randomized, controlled trial. Dig Dis Sci 1991; 36:92–96.
- Sinclair SB, Greig PD, Blendis LM, Abecassis M, Roberts EA, Phillips MJ, et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E: a preliminary report. J Clin Invest 1989; 84:1063–1069.
- O’Grady JG, Gimson AE, O’Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroent-erology 1988; 94(Pt 1):1186–1192.
- Redeker AG, Yamahiro HS. Controlled trial of exchange-transfusion therapy in fulminant hepatitis. Lancet 1973; 1:3–6.
- McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of King’s College Hospital Criteria in prediction of outcome in nonparacetamol-induced acute liver failure. J Hepatol 2010; 53: 492-499.
- O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97(2):439-445.
- Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
- Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen induced liver injury. Hepatology 2007;45:789-796.
- Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, et al MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007;13:822-828
- Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130:1652- 1660
- Xiol X, Gines P, Castells L, Twose Riba Fuente Arderiu X, et al. Clinically relevant differencesin the model for end-stage liver disease and model for end-stage liver disease. Liver Transpl 2009; 15:300-305
- Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podestá Villamil FG. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007;13:822-82
- Zaman MB, Hoti E, Qasim A, et al. MELD score as a prognostic model for listingacute liver failure patients for liver transplantation. Transplant Proc 2006; 38:2097e8.
- Katoonizadeh A, Decaestecker J, Wilmer A, et al. MELD score to predict outcomein adult patients with non-acetaminophen-induced acute liver failure. Liver Int2007;27:329e34.
- Du WB, Pan XP, Li LJ. Prognostic models for acute liver failure. Hepatobiliary Pancreat Dis Int 2010;9:122e8.
- Shakil AO, Kramer D, Mazariegos GV, et al. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6:163e9.
- Ramesh kumar, Shalimar 2012 Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure, gut bmj2012).
- V Bhatia, R Singh, S K Acharya: Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 2006;55:98–104.
